J. Goldman & CO LP Eli Lilly & CO Put Options Transaction History

J. Goldman & CO LP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $5.8 Million - $7.27 Million	8,000 New	8,000 $7.24 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $2.73 Million - $3.22 Million	5,200 New	5,200 $3.03 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $6.21 Million - $8.3 Million	-17,700 Reduced 66.79%	8,800 $4.13 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $8.23 Million - $9.67 Million	26,500 New	26,500 $9.1 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $2.96 Million - $3.38 Million	10,000 New	10,000 $3.23 Million

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.